Aliases:This biomarker is also known as:
- free prostate-specific antigen (PSA) isoform,
ProPSA (-2), or [-2]proPSA, is a PSA isoform which has a leader peptide (-2) amino acids at its N terminal region and does not interact with ACT or alpha-2-macroglobulin or spermidine and therefore is detected as a separate isoform. ProPSA is produced primarily in the peripheral zone of the prostate gland and therefore is very useful in distinguishing between prostate cancer patients with PSA range of 2-10, from those who have BPH. Percent proPSA is the ratio of proPSA to free PSA. In July 2012 the FDA approved an assay measuring levels of [-2]proPSA for monitoring and diagnostic purposes.
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
The measurement of PSA, free PSA, and pro-PSA can help a patient determine whether to undergo biopsy if his PSA level is between 4 and 10 ng/mL.
In July 2012 the FDA approved an assay measuring levels of [-2]proPSA, a form of pro-PSA, for monitoring and diagnostic purposes.
- Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay.
- Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).
- Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers.
- HGNC entry for from Genenames
- KEGG entry for from Genome.jp
- Entrez entry for all NCBI Databasese
- Human GEO Profiles for from NCBI GEO Profiles
- Human Geo Datasets containing term from NCBI GEO Datasets
- GWAS Study Datasets containing gene from GWAS
- Human Single Nucleotide Polymorphisms info for
- Human Gene(s) with '' as Gene Name/Alias
- Human Gene RefSeq for from NCBI
- GeneCards entry for human
- UniProtKB/Swiss-Prot entry for from Uniprot
- Human Protein RefSeq for from NCBI
- FDA web page describing approval of
No associated Biomuta entries found.